1. U.S. Food and Drug Administration.CDER patient‐focused drug development. . Accessed September 2018.
2. Enhancing the incorporation of the patient's voice in drug development and evaluation;Chalasani M.;Restor. Neurol. Neurosci.,2018
3. U.S. Food and Drug Administration.FDA patient‐focused drug development guidance series for enhancing the incorporation of the patient's voice in medical product development and regulatory decision making. Accessed September 2018.
4. U.S. Food and Drug Administration.External resources or information related to patients’ experience. Accessed September 2018.
5. U.S. Food and Drug Administration.FDA standard core clinical outcome assessments and endpoints. Accessed September 2018.